Graziano JH - Search Results

1

Effects of iron chelators and iron overload on Salmonella infection.

Jones RL, Peterson CM, Grady RW, Kumbaraci T, Cerami A, Graziano JH. Jones RL, et al. Among authors: graziano jh. Nature. 1977 May 5;267(5606):63-5. doi: 10.1038/267063a0. Nature. 1977. PMID: 323727 No abstract available.

2

The identification of 2, 3-dihydroxybenzoic acid as a potentially useful iron-chelating drug.

Graziano JH, Grady RW, Cerami A. Graziano JH, et al. J Pharmacol Exp Ther. 1974 Sep;190(3):570-5. J Pharmacol Exp Ther. 1974. PMID: 4416298 No abstract available.

3

Rhodotorulic acid--investigation of its potential as an iron-chelating drug.

Grady RW, Peterson CM, Jones RL, Graziano JH, Bhargava KK, Berdoukas VA, Kokkini G, Loukopoulos D, Cerami A. Grady RW, et al. Among authors: graziano jh. J Pharmacol Exp Ther. 1979 Jun;209(3):342-8. J Pharmacol Exp Ther. 1979. PMID: 108388

4

2,3-DHB ineffective in treatment of iron overload.

Peterson CM, Grady RW, Jones RL, Cerami A, Graziano JH, Markenson AL, Lavi U, Canale V, Gray GF, Miller DR. Peterson CM, et al. Among authors: graziano jh. N Engl J Med. 1977 Dec 22;297(25):1404. doi: 10.1056/nejm197712222972518. N Engl J Med. 1977. PMID: 337140 Clinical Trial. No abstract available.

5

The development of new iron-chelating drugs. II.

Grady RW, Graziano JH, White GP, Jacobs A, Cerami A. Grady RW, et al. Among authors: graziano jh. J Pharmacol Exp Ther. 1978 Jun;205(3):575-65. J Pharmacol Exp Ther. 1978. PMID: 660531

6

Chelation studies with 2,3-dihydroxybenzoic acid in patients with beta-thalassaemia major.

Peterson CM, Graziano JH, Grady RW, Jones RL, Vlassara HV, Canale VC, Miller DR, Cerami A. Peterson CM, et al. Among authors: graziano jh. Br J Haematol. 1976 Aug;33(4):477-85. doi: 10.1111/j.1365-2141.1976.tb03566.x. Br J Haematol. 1976. PMID: 1009020

7

Chelation therapy for the treatment of thalassemia.

Graziano JH, Cerami A. Graziano JH, et al. Semin Hematol. 1977 Jan;14(1):127-34. Semin Hematol. 1977. PMID: 318766 Review. No abstract available.

8

The development of new iron-chelating drugs.

Grady RW, Graziano JH, Akers HA, Cerami A. Grady RW, et al. Among authors: graziano jh. J Pharmacol Exp Ther. 1976 Feb;196(2):478-85. J Pharmacol Exp Ther. 1976. PMID: 1255491

9

Chelation therapy in beta-thalassemia major: a one-year double blind study of 2,3-dihydroxybenzoic acid.

Peterson CM, Graziano JH, Grady RW, Jones RL, Markenson A, Lavi U, Canale V, Gray GF, Cerami A, Miller DR. Peterson CM, et al. Among authors: graziano jh. Exp Hematol. 1979 Feb;7(2):74-80. Exp Hematol. 1979. PMID: 371974 Clinical Trial.

10

Iron metabolism, sickle cell disease, and response to cyanate.

Peterson CM, Graziano JH, de Ciutiis A, Grady RW, Cerami A, Worwood M, Jacobs A. Peterson CM, et al. Among authors: graziano jh. Blood. 1975 Oct;46(4):583-90. Blood. 1975. PMID: 1174692 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

259 results

Search Page

Filters